References
- Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 2007;68:1076-1077. https://doi.org/10.1212/01.wnl.0000256822.01222.bd
- Shin CW, Kim SH, Cho SY, Chang JY, Kim SM, Lee KW. Steroid unresponsive neuromyelitis optica improved with plasmapheresis. J Korean Neurol Assoc 2009;27:417-420.
- Watanabe S, Nakashima I, Misu T, Miyazawa I, Shiga Y, Fujihara K, et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 2007;13:128-132. https://doi.org/10.1177/1352458506071174
- Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA, Weinshenker BG. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology 2007;68:603-605. https://doi.org/10.1212/01.wnl.0000254502.87233.9a
- Weinshenker BG. Plasma exchange for severe attacks of inflammatory demyelinating diseases of the central nervous system. J Clin Apher 2001;16:39-42. https://doi.org/10.1002/jca.1010
- Keegan M, Pineda AA, McCelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyeliation: predictors of response. Neurology 2002;58:143-146. https://doi.org/10.1212/WNL.58.1.143
- Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A. Evidence-based guideline update: plasmapheresis in neurologic disorders. Neurology 2011;76:294. https://doi.org/10.1212/WNL.0b013e318207b1f6